Toll-like receptor 4–induced inflammatory responses contribute to the tumor-associated macrophages formation and infiltration in patients with diffuse large B-cell lymphoma

Abstract To evaluate the expression of tumor-associated macrophages (TAMs) and Toll-like receptor 4 (TLR4) in diffuse large B-cell lymphoma (DLBCL) and their correlation with patient clinical characteristics, we detected using immunohistochemistry in 81 specimens of patients with DLBCL. The correlat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of diagnostic pathology 2015-08, Vol.19 (4), p.232-238
Hauptverfasser: Wang, Xiaofang, MD, Li, Xiangli, MS, Zhang, Xiaoying, MS, Zang, Li, MS, Yang, Hongliang, MS, Zhao, Weipeng, MD, Zhao, Haifeng, MD, Li, Qian, MS, Xia, Bing, MS, Yu, Yong, MD, Wang, Yafei, MD, Zhao, Zhigang, MD, Zhang, Yizhuo, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 238
container_issue 4
container_start_page 232
container_title Annals of diagnostic pathology
container_volume 19
creator Wang, Xiaofang, MD
Li, Xiangli, MS
Zhang, Xiaoying, MS
Zang, Li, MS
Yang, Hongliang, MS
Zhao, Weipeng, MD
Zhao, Haifeng, MD
Li, Qian, MS
Xia, Bing, MS
Yu, Yong, MD
Wang, Yafei, MD
Zhao, Zhigang, MD
Zhang, Yizhuo, PhD
description Abstract To evaluate the expression of tumor-associated macrophages (TAMs) and Toll-like receptor 4 (TLR4) in diffuse large B-cell lymphoma (DLBCL) and their correlation with patient clinical characteristics, we detected using immunohistochemistry in 81 specimens of patients with DLBCL. The correlation between protein expression levels and clinical parameters, as well as the association between CD68 and TLR4 were analyzed. The number of CD68 TAMs was closely related to β2 -microglobulin ( P = .028 and P < .05), whereas there was no significant correlation between the number of CD68 TAMs and other clinical factors. Toll-like receptor 4 was related to tumor size and peripheral blood lymphocyte to monocyte ratio. The Spearman correlation coefficient indicated a significant positive correlation between CD68 TAMs and TLR4 expression ( r = 0.240; P = .038, P = .05). These results, on one hand, indicated that TLR4-induced inflammatory responses may affect TAM infiltration and accumulation, and that TAMs and TLR4 may interact to play important roles in DLBCL microenvironment regulating the tumor growth, but, on the other hand demonstrated that both of TAMs and TLR4 had not only one side on DLBCL growth.
doi_str_mv 10.1016/j.anndiagpath.2015.04.008
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1695174053</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1092913415000829</els_id><sourcerecordid>1695174053</sourcerecordid><originalsourceid>FETCH-LOGICAL-c502t-3bbe0864b0fbf2b876d28ada366efd883b415271096ef8a35eff1c8d0b1c89313</originalsourceid><addsrcrecordid>eNqNUkuO1DAQjRCIGQaugMyOTYKdxOlkgwQtftJILBjWlmOXu93j2MF2QL3jDtxjDjUnoUIPCLFi47JL771y1auieMZoxSjrXhwq6b22cjfLvK9qynhF24rS_l5xznhTlz0b-vt4p0NdDqxpz4pHKR0oZazlm4fFWd3RDaO8PS9uroJzpbPXQCIomHOIpL39_sN6vSjQxHrj5DRJzB8RkebgEySigs_RjksGkgPJewzLFGIpUwrKyozMSaoY5r3cIdyEiBI2eCL9L03rcjwlrCfYhQWfE_lm855oa8ySgDgZd0BelwqcI-44zfswycfFAyNdgid38aL4_PbN1fZ9efnx3Yftq8tScVrnshlHoH3XjtSMph77TafrXmrZdB0Y3ffN2DJe4wgGfPey4WAMU72mI55Dw5qL4vlJd47hywIpi8mm9SfSQ1iSYN3A2aalvEHocIJiuylFMGKOdpLxKBgVq13iIP6yS6x2CdoKtAu5T-_KLOME-g_ztz8I2J4AgM1-tRBFUjgrdMaiXVnoYP-rzMt_VJSz3irpruEI6RCW6HGagolUCyo-rXuzrg3jFOn10PwEvATHsg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1695174053</pqid></control><display><type>article</type><title>Toll-like receptor 4–induced inflammatory responses contribute to the tumor-associated macrophages formation and infiltration in patients with diffuse large B-cell lymphoma</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Wang, Xiaofang, MD ; Li, Xiangli, MS ; Zhang, Xiaoying, MS ; Zang, Li, MS ; Yang, Hongliang, MS ; Zhao, Weipeng, MD ; Zhao, Haifeng, MD ; Li, Qian, MS ; Xia, Bing, MS ; Yu, Yong, MD ; Wang, Yafei, MD ; Zhao, Zhigang, MD ; Zhang, Yizhuo, PhD</creator><creatorcontrib>Wang, Xiaofang, MD ; Li, Xiangli, MS ; Zhang, Xiaoying, MS ; Zang, Li, MS ; Yang, Hongliang, MS ; Zhao, Weipeng, MD ; Zhao, Haifeng, MD ; Li, Qian, MS ; Xia, Bing, MS ; Yu, Yong, MD ; Wang, Yafei, MD ; Zhao, Zhigang, MD ; Zhang, Yizhuo, PhD</creatorcontrib><description>Abstract To evaluate the expression of tumor-associated macrophages (TAMs) and Toll-like receptor 4 (TLR4) in diffuse large B-cell lymphoma (DLBCL) and their correlation with patient clinical characteristics, we detected using immunohistochemistry in 81 specimens of patients with DLBCL. The correlation between protein expression levels and clinical parameters, as well as the association between CD68 and TLR4 were analyzed. The number of CD68 TAMs was closely related to β2 -microglobulin ( P = .028 and P &lt; .05), whereas there was no significant correlation between the number of CD68 TAMs and other clinical factors. Toll-like receptor 4 was related to tumor size and peripheral blood lymphocyte to monocyte ratio. The Spearman correlation coefficient indicated a significant positive correlation between CD68 TAMs and TLR4 expression ( r = 0.240; P = .038, P = .05). These results, on one hand, indicated that TLR4-induced inflammatory responses may affect TAM infiltration and accumulation, and that TAMs and TLR4 may interact to play important roles in DLBCL microenvironment regulating the tumor growth, but, on the other hand demonstrated that both of TAMs and TLR4 had not only one side on DLBCL growth.</description><identifier>ISSN: 1092-9134</identifier><identifier>EISSN: 1532-8198</identifier><identifier>DOI: 10.1016/j.anndiagpath.2015.04.008</identifier><identifier>PMID: 26071054</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Antigens, CD - immunology ; Antigens, CD - metabolism ; Antigens, Differentiation, Myelomonocytic - immunology ; Antigens, Differentiation, Myelomonocytic - metabolism ; beta 2-Microglobulin - biosynthesis ; beta 2-Microglobulin - immunology ; Clinical parameters ; Diffuse large B-cell lymphoma (DLBCL) ; Female ; Germinal Center - immunology ; Germinal Center - metabolism ; Humans ; Immunohistochemistry ; Immunohistochemistry - methods ; Lymphoma, Large B-Cell, Diffuse - immunology ; Lymphoma, Large B-Cell, Diffuse - metabolism ; Lymphoma, Large B-Cell, Diffuse - pathology ; Macrophages - immunology ; Macrophages - pathology ; Male ; Middle Aged ; Pathology ; Prognosis ; Retrospective Studies ; Toll-like receptor 4 (TLR4) ; Toll-Like Receptor 4 - immunology ; Toll-Like Receptor 4 - metabolism ; Treatment Outcome ; Tumor-associated macrophages (TAMs)</subject><ispartof>Annals of diagnostic pathology, 2015-08, Vol.19 (4), p.232-238</ispartof><rights>Elsevier Inc.</rights><rights>2015 Elsevier Inc.</rights><rights>Copyright © 2015 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c502t-3bbe0864b0fbf2b876d28ada366efd883b415271096ef8a35eff1c8d0b1c89313</citedby><cites>FETCH-LOGICAL-c502t-3bbe0864b0fbf2b876d28ada366efd883b415271096ef8a35eff1c8d0b1c89313</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.anndiagpath.2015.04.008$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26071054$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Xiaofang, MD</creatorcontrib><creatorcontrib>Li, Xiangli, MS</creatorcontrib><creatorcontrib>Zhang, Xiaoying, MS</creatorcontrib><creatorcontrib>Zang, Li, MS</creatorcontrib><creatorcontrib>Yang, Hongliang, MS</creatorcontrib><creatorcontrib>Zhao, Weipeng, MD</creatorcontrib><creatorcontrib>Zhao, Haifeng, MD</creatorcontrib><creatorcontrib>Li, Qian, MS</creatorcontrib><creatorcontrib>Xia, Bing, MS</creatorcontrib><creatorcontrib>Yu, Yong, MD</creatorcontrib><creatorcontrib>Wang, Yafei, MD</creatorcontrib><creatorcontrib>Zhao, Zhigang, MD</creatorcontrib><creatorcontrib>Zhang, Yizhuo, PhD</creatorcontrib><title>Toll-like receptor 4–induced inflammatory responses contribute to the tumor-associated macrophages formation and infiltration in patients with diffuse large B-cell lymphoma</title><title>Annals of diagnostic pathology</title><addtitle>Ann Diagn Pathol</addtitle><description>Abstract To evaluate the expression of tumor-associated macrophages (TAMs) and Toll-like receptor 4 (TLR4) in diffuse large B-cell lymphoma (DLBCL) and their correlation with patient clinical characteristics, we detected using immunohistochemistry in 81 specimens of patients with DLBCL. The correlation between protein expression levels and clinical parameters, as well as the association between CD68 and TLR4 were analyzed. The number of CD68 TAMs was closely related to β2 -microglobulin ( P = .028 and P &lt; .05), whereas there was no significant correlation between the number of CD68 TAMs and other clinical factors. Toll-like receptor 4 was related to tumor size and peripheral blood lymphocyte to monocyte ratio. The Spearman correlation coefficient indicated a significant positive correlation between CD68 TAMs and TLR4 expression ( r = 0.240; P = .038, P = .05). These results, on one hand, indicated that TLR4-induced inflammatory responses may affect TAM infiltration and accumulation, and that TAMs and TLR4 may interact to play important roles in DLBCL microenvironment regulating the tumor growth, but, on the other hand demonstrated that both of TAMs and TLR4 had not only one side on DLBCL growth.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antigens, CD - immunology</subject><subject>Antigens, CD - metabolism</subject><subject>Antigens, Differentiation, Myelomonocytic - immunology</subject><subject>Antigens, Differentiation, Myelomonocytic - metabolism</subject><subject>beta 2-Microglobulin - biosynthesis</subject><subject>beta 2-Microglobulin - immunology</subject><subject>Clinical parameters</subject><subject>Diffuse large B-cell lymphoma (DLBCL)</subject><subject>Female</subject><subject>Germinal Center - immunology</subject><subject>Germinal Center - metabolism</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Immunohistochemistry - methods</subject><subject>Lymphoma, Large B-Cell, Diffuse - immunology</subject><subject>Lymphoma, Large B-Cell, Diffuse - metabolism</subject><subject>Lymphoma, Large B-Cell, Diffuse - pathology</subject><subject>Macrophages - immunology</subject><subject>Macrophages - pathology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Pathology</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><subject>Toll-like receptor 4 (TLR4)</subject><subject>Toll-Like Receptor 4 - immunology</subject><subject>Toll-Like Receptor 4 - metabolism</subject><subject>Treatment Outcome</subject><subject>Tumor-associated macrophages (TAMs)</subject><issn>1092-9134</issn><issn>1532-8198</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNUkuO1DAQjRCIGQaugMyOTYKdxOlkgwQtftJILBjWlmOXu93j2MF2QL3jDtxjDjUnoUIPCLFi47JL771y1auieMZoxSjrXhwq6b22cjfLvK9qynhF24rS_l5xznhTlz0b-vt4p0NdDqxpz4pHKR0oZazlm4fFWd3RDaO8PS9uroJzpbPXQCIomHOIpL39_sN6vSjQxHrj5DRJzB8RkebgEySigs_RjksGkgPJewzLFGIpUwrKyozMSaoY5r3cIdyEiBI2eCL9L03rcjwlrCfYhQWfE_lm855oa8ySgDgZd0BelwqcI-44zfswycfFAyNdgid38aL4_PbN1fZ9efnx3Yftq8tScVrnshlHoH3XjtSMph77TafrXmrZdB0Y3ffN2DJe4wgGfPey4WAMU72mI55Dw5qL4vlJd47hywIpi8mm9SfSQ1iSYN3A2aalvEHocIJiuylFMGKOdpLxKBgVq13iIP6yS6x2CdoKtAu5T-_KLOME-g_ztz8I2J4AgM1-tRBFUjgrdMaiXVnoYP-rzMt_VJSz3irpruEI6RCW6HGagolUCyo-rXuzrg3jFOn10PwEvATHsg</recordid><startdate>20150801</startdate><enddate>20150801</enddate><creator>Wang, Xiaofang, MD</creator><creator>Li, Xiangli, MS</creator><creator>Zhang, Xiaoying, MS</creator><creator>Zang, Li, MS</creator><creator>Yang, Hongliang, MS</creator><creator>Zhao, Weipeng, MD</creator><creator>Zhao, Haifeng, MD</creator><creator>Li, Qian, MS</creator><creator>Xia, Bing, MS</creator><creator>Yu, Yong, MD</creator><creator>Wang, Yafei, MD</creator><creator>Zhao, Zhigang, MD</creator><creator>Zhang, Yizhuo, PhD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150801</creationdate><title>Toll-like receptor 4–induced inflammatory responses contribute to the tumor-associated macrophages formation and infiltration in patients with diffuse large B-cell lymphoma</title><author>Wang, Xiaofang, MD ; Li, Xiangli, MS ; Zhang, Xiaoying, MS ; Zang, Li, MS ; Yang, Hongliang, MS ; Zhao, Weipeng, MD ; Zhao, Haifeng, MD ; Li, Qian, MS ; Xia, Bing, MS ; Yu, Yong, MD ; Wang, Yafei, MD ; Zhao, Zhigang, MD ; Zhang, Yizhuo, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c502t-3bbe0864b0fbf2b876d28ada366efd883b415271096ef8a35eff1c8d0b1c89313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antigens, CD - immunology</topic><topic>Antigens, CD - metabolism</topic><topic>Antigens, Differentiation, Myelomonocytic - immunology</topic><topic>Antigens, Differentiation, Myelomonocytic - metabolism</topic><topic>beta 2-Microglobulin - biosynthesis</topic><topic>beta 2-Microglobulin - immunology</topic><topic>Clinical parameters</topic><topic>Diffuse large B-cell lymphoma (DLBCL)</topic><topic>Female</topic><topic>Germinal Center - immunology</topic><topic>Germinal Center - metabolism</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Immunohistochemistry - methods</topic><topic>Lymphoma, Large B-Cell, Diffuse - immunology</topic><topic>Lymphoma, Large B-Cell, Diffuse - metabolism</topic><topic>Lymphoma, Large B-Cell, Diffuse - pathology</topic><topic>Macrophages - immunology</topic><topic>Macrophages - pathology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Pathology</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><topic>Toll-like receptor 4 (TLR4)</topic><topic>Toll-Like Receptor 4 - immunology</topic><topic>Toll-Like Receptor 4 - metabolism</topic><topic>Treatment Outcome</topic><topic>Tumor-associated macrophages (TAMs)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Xiaofang, MD</creatorcontrib><creatorcontrib>Li, Xiangli, MS</creatorcontrib><creatorcontrib>Zhang, Xiaoying, MS</creatorcontrib><creatorcontrib>Zang, Li, MS</creatorcontrib><creatorcontrib>Yang, Hongliang, MS</creatorcontrib><creatorcontrib>Zhao, Weipeng, MD</creatorcontrib><creatorcontrib>Zhao, Haifeng, MD</creatorcontrib><creatorcontrib>Li, Qian, MS</creatorcontrib><creatorcontrib>Xia, Bing, MS</creatorcontrib><creatorcontrib>Yu, Yong, MD</creatorcontrib><creatorcontrib>Wang, Yafei, MD</creatorcontrib><creatorcontrib>Zhao, Zhigang, MD</creatorcontrib><creatorcontrib>Zhang, Yizhuo, PhD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of diagnostic pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Xiaofang, MD</au><au>Li, Xiangli, MS</au><au>Zhang, Xiaoying, MS</au><au>Zang, Li, MS</au><au>Yang, Hongliang, MS</au><au>Zhao, Weipeng, MD</au><au>Zhao, Haifeng, MD</au><au>Li, Qian, MS</au><au>Xia, Bing, MS</au><au>Yu, Yong, MD</au><au>Wang, Yafei, MD</au><au>Zhao, Zhigang, MD</au><au>Zhang, Yizhuo, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Toll-like receptor 4–induced inflammatory responses contribute to the tumor-associated macrophages formation and infiltration in patients with diffuse large B-cell lymphoma</atitle><jtitle>Annals of diagnostic pathology</jtitle><addtitle>Ann Diagn Pathol</addtitle><date>2015-08-01</date><risdate>2015</risdate><volume>19</volume><issue>4</issue><spage>232</spage><epage>238</epage><pages>232-238</pages><issn>1092-9134</issn><eissn>1532-8198</eissn><abstract>Abstract To evaluate the expression of tumor-associated macrophages (TAMs) and Toll-like receptor 4 (TLR4) in diffuse large B-cell lymphoma (DLBCL) and their correlation with patient clinical characteristics, we detected using immunohistochemistry in 81 specimens of patients with DLBCL. The correlation between protein expression levels and clinical parameters, as well as the association between CD68 and TLR4 were analyzed. The number of CD68 TAMs was closely related to β2 -microglobulin ( P = .028 and P &lt; .05), whereas there was no significant correlation between the number of CD68 TAMs and other clinical factors. Toll-like receptor 4 was related to tumor size and peripheral blood lymphocyte to monocyte ratio. The Spearman correlation coefficient indicated a significant positive correlation between CD68 TAMs and TLR4 expression ( r = 0.240; P = .038, P = .05). These results, on one hand, indicated that TLR4-induced inflammatory responses may affect TAM infiltration and accumulation, and that TAMs and TLR4 may interact to play important roles in DLBCL microenvironment regulating the tumor growth, but, on the other hand demonstrated that both of TAMs and TLR4 had not only one side on DLBCL growth.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26071054</pmid><doi>10.1016/j.anndiagpath.2015.04.008</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1092-9134
ispartof Annals of diagnostic pathology, 2015-08, Vol.19 (4), p.232-238
issn 1092-9134
1532-8198
language eng
recordid cdi_proquest_miscellaneous_1695174053
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Adult
Aged
Aged, 80 and over
Antigens, CD - immunology
Antigens, CD - metabolism
Antigens, Differentiation, Myelomonocytic - immunology
Antigens, Differentiation, Myelomonocytic - metabolism
beta 2-Microglobulin - biosynthesis
beta 2-Microglobulin - immunology
Clinical parameters
Diffuse large B-cell lymphoma (DLBCL)
Female
Germinal Center - immunology
Germinal Center - metabolism
Humans
Immunohistochemistry
Immunohistochemistry - methods
Lymphoma, Large B-Cell, Diffuse - immunology
Lymphoma, Large B-Cell, Diffuse - metabolism
Lymphoma, Large B-Cell, Diffuse - pathology
Macrophages - immunology
Macrophages - pathology
Male
Middle Aged
Pathology
Prognosis
Retrospective Studies
Toll-like receptor 4 (TLR4)
Toll-Like Receptor 4 - immunology
Toll-Like Receptor 4 - metabolism
Treatment Outcome
Tumor-associated macrophages (TAMs)
title Toll-like receptor 4–induced inflammatory responses contribute to the tumor-associated macrophages formation and infiltration in patients with diffuse large B-cell lymphoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T11%3A05%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Toll-like%20receptor%204%E2%80%93induced%20inflammatory%20responses%20contribute%20to%20the%20tumor-associated%20macrophages%20formation%20and%20infiltration%20in%20patients%20with%20diffuse%20large%20B-cell%20lymphoma&rft.jtitle=Annals%20of%20diagnostic%20pathology&rft.au=Wang,%20Xiaofang,%20MD&rft.date=2015-08-01&rft.volume=19&rft.issue=4&rft.spage=232&rft.epage=238&rft.pages=232-238&rft.issn=1092-9134&rft.eissn=1532-8198&rft_id=info:doi/10.1016/j.anndiagpath.2015.04.008&rft_dat=%3Cproquest_cross%3E1695174053%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1695174053&rft_id=info:pmid/26071054&rft_els_id=1_s2_0_S1092913415000829&rfr_iscdi=true